Advertisement

Quality of Life and Stigma

  • A. Tsutsumi
  • T. Izutsu

Abstract:

 Stigma is a historical and social phenomenon that has influenced a variety of aspects of human life. Particular diseases, such as  leprosy, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV and AIDS), and  epilepsy among others, are typical examples of diseases affected by stigma. A variety of reports have shown strong and significant rates of stigma against people with these diseases by the general population and even by their families and health workers in different societies. Resulting deterioration in the mental health, such as depression, anxiety and somatic symptoms, of these people has also been reported. Pioneering studies have revealed that quality of life (QOL) is most significantly lowered by the presence of  perceived stigma, which represents the internal belief of affected people that they are being stigmatized, rather than the actual stigmatic beliefs and behaviors rendered by others. Previous efforts of international communities such as  United Nations (UN) systems, non-governmental organizations (NGOs) and other stakeholders have mainly been aimed at decreasing the prevalence and incidence of such diseases. However, it is imperative to pay sufficient attention to the QOL and stigmatization of people with these diseases in terms of their human rights, dignity, and physical, mental and social well-being.

Integrating perspectives on stigma and QOL among people who are living with diseases susceptible to stigmatization into existing internationally prioritized development strategies, policies and programs, e.g.,  Millennium Development Goals (MDGs), with long-term perspectives is important. Further empirical studies on this issue and implementation and evaluation of the strategies, policies and programs are warranted.

Keywords

Anorexia Nervosa Sexual Minority Leprosy Patient General Mental Health Affected People 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

ADL

Activities of daily living

AIDS

Acquired immunodeficiency Syndrome

ANCOVA

Analysis of covariance

HIV

Human immunodeficiency virus

MDGs

Millennium Development Goals

NGOs

Non governmental organizations

QOL

Quality of life

SRQ

 Self-Reporting Questionnaire

STIs

Sexually transmitted infections

UN

United Nations

WHO

 World Health Organization

WHOQOL-BREF

 World Health Organization Quality of Life BREF

References

  1. Baker GA, Brooks J, Buck D, Jacoby A. (2000). Epilepsia. 41: 98–104.PubMedCrossRefGoogle Scholar
  2. Bechdolf A, Klosterkotter J, Hambrecht M, Knost B, Kuntermann C, Schiller S, Pukrop R. (2003). Psychiatr Clin Neurosci. 253: 228–235.CrossRefGoogle Scholar
  3. Behere PB. (1981). Lepr India. 53: 266–272.PubMedGoogle Scholar
  4. Blume W, Lüders H, Mizrahi E, Tassinari C, van Emde Boas W, Engel J. (2001). Epilepsia.42: 1212–1218.PubMedCrossRefGoogle Scholar
  5. Briden A, Maguire E. (2003). Lepr Rev. 74: 154–162.PubMedGoogle Scholar
  6. Bryceson A, Pfaltzgraff RE. (1990). Leprosy, 3rd ed. Churchill Livingston, New York.Google Scholar
  7. Commission on Epidemiology and Prognosis, International League Against Epilepsy. (1993). Epilepsia. 34: 592–596.Google Scholar
  8. Croft RP, Croft RA. (1998). Lepr Rev. 70: 34–42.Google Scholar
  9. DiIorio C, Osborne SP, Letz R, Henry T, Schomer DL, Yeager K; (2003). Project EASE Study Group. Epilepsy Behav. 4: 259–267.PubMedCrossRefGoogle Scholar
  10. Dlamini PS, Kohi TW, Uys LR, Phetlhu RD, Chirwa ML, Naidoo JR, Holzemer WL, Greeff M, Makoae LN. (2007). Public Health Nurs. 24: 389–399.PubMedCrossRefGoogle Scholar
  11. El-Gadi S, Abudher A, Sammud M. (2008). Int J STD AIDS. 19: 178–183.PubMedCrossRefGoogle Scholar
  12. Elissen MC. (1991). Trop Geogr Med. 43: 379–382.PubMedGoogle Scholar
  13. Fisher R, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J. (2005). Epilepsia 46: 470–472.PubMedCrossRefGoogle Scholar
  14. Floyd-Richard M, Gurung S. (2000). Lepr Rev. 71: 499–504.PubMedGoogle Scholar
  15. Gerochi LN. (1986). SE Asian J Trop Med Public Health. 17: 422–426.Google Scholar
  16. Goffman E. (1963). Stigma: Notes on the Management of Spoiled Identity. Prentice-Hall, Englewood Cliffs.Google Scholar
  17. Gussow Z. (1989). Leprosy, Racism, and Public Health: Social Policy in Chronic Disease Control. Westview, Boulder.Google Scholar
  18. Hyland JA. (1993). A socio-cultural study of leprosy in Nepal: compliance, patient illness career patterns, and health education. Ph.D. Dissertation, University of Tasmania.Google Scholar
  19. Joseph GA, Rao S. (1999). Bull World Health Organ. 77: 515–517.PubMedGoogle Scholar
  20. Kaur H, Ramesh V. (1994). Lepr Rev. 65: 361–375.PubMedGoogle Scholar
  21. Kumaresan JA, Maganu ET. (1994a). East Afr Med J. 71: 366–367.PubMedGoogle Scholar
  22. Kumaresan JA, Maganu ET. (1994b). Soc Sci Med. 39: 537–541.PubMedCrossRefGoogle Scholar
  23. Kushwah SS, Govila AK, Upadhyay S, Kushwah J. (1981). Lepr India. 53: 221–225.PubMedGoogle Scholar
  24. Mhasawade BC. (1983). Lepr India. 55: 310–313.PubMedGoogle Scholar
  25. Minnock P, Fitzgerald O, Bresnihan B. (2003). Arthritis Rheum. 49: 221–227.PubMedCrossRefGoogle Scholar
  26. Nguyen TA, Oosterhoff P, Pham Ngoc Y, Wright P, Hardon A. (2008). AIDS Res Ther. 5: 7.PubMedCrossRefGoogle Scholar
  27. Noorden SK. (1995). Bull World Health Organ. 73: 1–6.Google Scholar
  28. Parker PA, Baile WF, Moor C, Cohen L. (2003). Psycho-Oncol. 12: 183–193.CrossRefGoogle Scholar
  29. Pramanik S, Chartier M, Koopman C. (2006). J Commun Dis. 38: 57–69.PubMedGoogle Scholar
  30. Qubati Y, Kubati AS. (1997). Int J Dermatol. 36: 920–922.CrossRefGoogle Scholar
  31. Raj V, Carg BR, Lals. (1981). Lepr India. 53: 226–230.Google Scholar
  32. Rajaratnam J, Abel R, Arumai M. (1999). Lepr Rev. 70: 28–33.PubMedGoogle Scholar
  33. Ranjit Kumar JH, Verghese A. (1980). Int J Lepr Other Mycobact Dis. 48: 431–434.Google Scholar
  34. Rehse B, Pukrop R. (2003). Patient Educ Counsel. 50: 179–186.Google Scholar
  35. Remor E. (2002). Atencion Primaria. 30: 143–148.PubMedGoogle Scholar
  36. Scott J. (2000). Lepr Rev. 71: 486–491.Google Scholar
  37. Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. (2007). Soc Sci Med. 64: 1823–1831.PubMedCrossRefGoogle Scholar
  38. Snyder M, Omoto AM, Crain AL. (1999). Am Behav Scientist. 42: 1175–1192.CrossRefGoogle Scholar
  39. Srinvasan H. (1993). Prevention of Disability in Patients with Leprosy. A Practical Guide. World Health Organization, Geneva.Google Scholar
  40. Suite M, Gittens C. (1992). Lepr Rev. 63: 151–156.PubMedGoogle Scholar
  41. Tarwireyi F. (2005). Cent Afr J Med. 51: 71–76.PubMedGoogle Scholar
  42. Tekle-Haimanot R, Forsgren L, Gebre-Mariam A, Abebe M, Holmgren G, Heijbel J, Ekstedt J. (1992). Lepr Rev. 63: 157–168.PubMedGoogle Scholar
  43. Tsutsumi A, Izutsu T, Akramul Islam MD, Amed JU, Nakahara S, Takagi F, Wakai S. (2004). Lepr Rev. 75: 57–66.PubMedGoogle Scholar
  44. Tsutsumi A, Izutsu T, Islam AM, Maksuda AN, Kato H, Wakai S. (2007). Soc Sci Med. 64: 2443–2453.PubMedCrossRefGoogle Scholar
  45. Vranceanu AM, Safren SA, Lu M, Coady WM, Skolnik PR, Rogers WH, Wilson IB. (2008). AIDS Patient Care STDs. 22: 313–321.PubMedCrossRefGoogle Scholar
  46. Weiss MG, Doongaji DR, Siddhartha S, Wypij D, Pathare S, Bhatawdekar M, Bhave A, Sheth A, Fernandes R. (1992). Br J Psychiatry. 160: 819–830.PubMedCrossRefGoogle Scholar
  47. Wingood GM, Diclemente RJ, Mikhail I, McCree DH, Davies SL, Hardin JW, Harris Peterson S, Hook EW, Saag M. (2007). Women Health. 46: 99–112.PubMedGoogle Scholar
  48. World Health Organization. (1994). A User’s Guide to the Self-Reporting Questionnaire (SRQ). World Health Organization, Geneva.Google Scholar
  49. World Health Organization. (1996). WHOQOL-BREF Instruction, Administration, Scoring and Generic Version of the Assessment. World Health Organization, Geneva.Google Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • A. Tsutsumi
    • 1
  • T. Izutsu
    • 2
  1. 1.Institute of Biomedical Research and Innovation (IBRI)KobeJapan
  2. 2.Department of Mental HealthGraduate School of Medicine, The University of TokyoTokyoJapan

Personalised recommendations